EGFR and cancer: In CRC the main gene with copy number variation related to the disease is EGFR. The pivotal role of EGFR in cancer progression is used in the treatment of RAS wild-type metastatic CRC by EGFR-targeting monoclonal antibodies cetuximab and panitumumab [117,118,119,120,121,122,123].